Medtronic is a large and diversified medical device company with a history of innovation. It has also consistently raised its dividend and is closing in now on Dividend King status.

Medtronic (NYSE: MDT) executives used the company's latest earnings call to highlight accelerating growth in several product areas, progress on multiple U.S. launches, and reiterated financial guidance for fiscal 2026 while maintaining an outlook for high single-digit adjusted EPS growth in fiscal 2027. Growth drivers: hypertension, pelvic health, and U.S. surgical robotics Management emphasized progress beyond

Medtronic PLC (NYSE: MDT) posted better-than-expected earnings for the third quarter on Tuesday.

Pre-Market Stock Futures: Futures are trading higher after a sluggish start to the holiday-shortened trading week. While stocks started as if it were going to be another risk-off day, they turned positive by late morning, and all the indices ended the day modestly higher. With a trove of economic data on the way, and fourth-quarter... Here Are Wednesday's Top Wall Street Analyst Research Calls: Cadence Design, Crox, Genuine Parts, Kratos Defense, Medtronic, Palantir, StubHub, Transocean, and More.

Medtronic's NYSE: MDT stock price is amid a textbook reversal, having formed a Head & Shoulders Pattern and broken to fresh highs, confirming the baseline as a critical pivot point. The question now is how high the stock might rise.

Adjusted earnings of $1.36 per share also beat expectations of $1.33.

Medtronic plc (MDT) Q3 2026 Earnings Call Transcript

Medtronic tops Q3 revenue and EPS estimates as Cardiovascular and Diabetes drive growth, but margin contraction tempers the upbeat quarter.

The headline numbers for Medtronic (MDT) give insight into how the company performed in the quarter ended January 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Medtronic (NYSE: MDT) delivered its strongest enterprise revenue growth in 10 quarters, posting 8.7% reported growth (6.0% organic) for Q3 fiscal 2026.